Tech Firm Saves Ohioans $11M on Drugs by Targeting Pharmacy Waste

AUSTIN, Texas – January 30, 2026 – A novel technology platform has quietly generated over $11 million in prescription drug savings for health plans and residents across Ohio, marking a significant victory in the state's battle against escalating healthcare costs. The savings, announced today by health tech innovator RazorMetrics, have impacted nearly 60,000 covered individuals by systematically identifying and eliminating pharmacy waste directly at the point of care.

The achievement highlights a pivotal shift in how healthcare costs can be managed—not by shifting financial burdens onto patients or restricting access, but by empowering physicians with data-driven tools embedded within their daily routines.

A New Prescription for Cost Control

At the heart of the savings is RazorMetrics' proprietary software, which integrates directly and unobtrusively into the electronic health record (EHR) systems used by physicians. Rather than requiring doctors to log into a separate portal or learn a new program, the technology works in the background to analyze prescriptions in real-time. It flags opportunities to reduce costs without compromising clinical outcomes.

These opportunities go far beyond simple generic-for-brand swaps. The platform targets what the company calls "avoidable pharmacy waste," a multifaceted problem that includes duplicative therapies, where a patient is prescribed multiple drugs for the same condition; unnecessary oversupply; and chances to switch to a clinically appropriate but lower-cost alternative, such as a biosimilar. It also identifies moments for "deprescribing"—the carefully managed process of stopping a medication that is no longer providing a benefit.

"There are clear inefficiencies in prescribing and pharmacy workflows that cause medications to be more expensive than they need to be," said Dr. Siva Mohan, Chief Medical Officer and President of RazorMetrics. "By identifying cost-saving opportunities for physicians, we help them reduce financial burden without changing patient care."

This physician-centric approach appears to be highly effective. The company reports that physicians accept its AI-driven suggestions at a high rate, with some studies showing up to 83% compliance. This success is largely attributed to the seamless integration and the assurance that all suggestions are aligned with the patient's specific health plan and formulary preferences.

Ohio's Battle Against Soaring Drug Prices

The $11 million in savings is particularly resonant in Ohio, where the high cost of prescription drugs has become a critical issue for a large segment of the population. A recent survey conducted in late 2024 revealed that 53% of Ohio adults were worried about their ability to afford their medications. This financial strain is more than just a budget concern; it is a significant public health challenge.

High drug costs are a primary driver of medication non-adherence, where patients skip doses, cut pills in half, or fail to fill prescriptions altogether to save money. This behavior is linked to poorer health outcomes, increased hospitalizations, and higher mortality rates. By directly lowering the out-of-pocket cost for patients at the pharmacy counter, solutions that reduce overall drug spend can have a powerful, positive ripple effect on public health.

Ohio's state government has actively sought solutions to control healthcare expenditures. However, the landscape is complex, with debates over the role of drug manufacturer coupons and a growing demand for greater transparency from Pharmacy Benefit Managers (PBMs). Against this backdrop, RazorMetrics' model offers a different path forward—one that focuses on clinical efficiency rather than complex financial engineering or policy battles.

Shifting Power from Payers to Prescribers

Traditionally, the primary levers for controlling drug costs have been held by insurers and PBMs through tools like formularies, prior authorizations, and step therapies. While effective in some ways, these methods are often seen as burdensome by physicians and confusing for patients. RazorMetrics' strategy represents a fundamental shift by placing the power to control costs directly into the hands of the prescriber at the moment a clinical decision is made.

This approach challenges the conventional PBM model by fostering a more collaborative and transparent ecosystem. Instead of a top-down mandate, it provides a real-time, clinically relevant suggestion that benefits the patient, the provider, and the health plan simultaneously. This focus on waste reduction within the existing system is what allows the company to deliver results without the disruption commonly associated with cost-cutting initiatives.

"Ohio plans and employers are looking for solutions that deliver results without disruption," said Tom Dorsett, CEO of RazorMetrics. "These savings show that meaningful cost reduction is possible by addressing waste inside the pharmacy benefit, rather than shifting risk or complexity onto members."

A Replicable Model for National Savings

The success in Ohio is not an isolated event. It builds on a proven track record established in other markets, most notably Texas. In 2025, the company reported an impressive $34 million in savings generated for 1.1 million members in Texas over a 24-month period. This demonstrates that the model is not only effective but also highly scalable across different populations, plan types, and state regulatory environments.

With an active network covering more than 525,000 prescribers across the nation and Puerto Rico, the potential for national impact is substantial. The company's rapid growth has not gone unnoticed. In 2025, RazorMetrics earned prominent placements on both the Inc. 5000 (No. 18) and Deloitte's Technology Fast 500 (No. 12), signaling strong market traction and investor confidence in its innovative approach.

Looking ahead to the remainder of 2026, the Austin-based firm plans to continue its expansion, evaluating other states where its clinically aligned approach can provide relief from pharmacy cost pressures. As health systems nationwide continue to grapple with the dual challenges of affordability and medication safety, empowering physicians to eliminate waste at the source presents a promising and powerful path forward.